ALISKIREN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 7 adverse event reports in the FDA FAERS database where ALISKIREN was used for Psoriasis.
Most Reported Side Effects for ALISKIREN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fall | 341 | 21.4% | 176 | 156 |
| Asthenia | 333 | 20.9% | 163 | 159 |
| Blood pressure increased | 303 | 19.0% | 168 | 79 |
| Nausea | 293 | 18.4% | 125 | 163 |
| Headache | 271 | 17.0% | 166 | 75 |
| Malaise | 268 | 16.8% | 160 | 91 |
| Vomiting | 240 | 15.1% | 142 | 90 |
| Cough | 237 | 14.9% | 165 | 62 |
| Fatigue | 236 | 14.8% | 148 | 73 |
| Pyrexia | 234 | 14.7% | 149 | 87 |
| Dyspnoea | 221 | 13.9% | 176 | 34 |
| Dizziness | 212 | 13.3% | 168 | 21 |
| Syncope | 204 | 12.8% | 157 | 40 |
| Diarrhoea | 195 | 12.2% | 172 | 14 |
| Cerebrovascular accident | 194 | 12.2% | 1 | 181 |
Other Indications for ALISKIREN
Product used for unknown indication (582)
Hypertension (546)
Cardiac failure (227)
Microalbuminuria (82)
Foetal exposure during pregnancy (54)
Off label use (49)
Cardiac failure chronic (48)
Cardiovascular disorder (25)
Blood pressure increased (18)
Blood pressure abnormal (11)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)